orogo
Demander un devis

Modified Nucleotides

5-Methylcytidine 5'-monophosphate, free acid

Quick view. 5-Methylcytidine 5'-monophosphate free acid, CAS 3590-36-1 and PubChem CID 192785. CAS 3590-36-1. Catalog target purity: By inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.

Request a quote Review request checklist

Chemical structure of 5-Methylcytidine 5'-monophosphate, free acid
Chemical structure
Catalog numberOR-MODN-0205
CAS number3590-36-1
PurityBy inquiry
Pack sizeCustom packaging by inquiry

Product profile

Material identity

5-Methylcytidine 5'-monophosphate, free acid is classified as modified nucleotides (Formula C10H16N3O8P; molecular weight 337.22 g/mol).

Typical application

5-Methylcytidine 5'-monophosphate, free acid — A defined 5-methylcytidine 5'-monophosphate free acid for structure-specific modified-ribonucleotide research and route development.

Handling focus

For 5-Methylcytidine 5'-monophosphate, free acid, confirm the current specification, storage conditions and downstream-method compatibility before routine use.

Names and search terms

Confirmed or normalized name variants

Useful catalog search terms

Physicochemical data

PubChem CID192785
InChIKeyNJQONZSFUKNYOY-JXOAFFINSA-N
Nucleotide form5'-Monophosphate free acid
InChIInChI=1S/C10H16N3O8P/c1-4-2-13(10(16)12-8(4)11)9-7(15)6(14)5(21-9)3-20-22(17,18)19/h2,5-7,9,14-15H,3H2,1H3,(H2,11,12,16)(H2,17,18,19)/t5-,6-,7-,9-/m1/s1
SMILESCC1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O

Release documentation

Lot-specific CoA

The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.

Analytical package

Additional HPLC, MS or NMR documentation can be agreed during technical review where available.

Related products

OR-INTE-0013

3'-OMe-GDP Disodium Salt

Modified Nucleotides · CAS: N/A

OR-INTE-0014

3'-OMe-GMP

Modified Nucleotides · CAS: 400806-41-9

OR-INTE-0015

3'-OMe-GMP TEA Salt

Modified Nucleotides · CAS: 860605-85-2

OR-INTE-0021

Im-3'-OMe-GMP

Modified Nucleotides · CAS: 1005791-93-4

OR-INTE-0023

Im-GDP

Modified Nucleotides · CAS: 1199264-75-9

OR-MN-0025

(-)-Emtricitabine Triphosphate Tetrasodium Salt

Modified Nucleotides · CAS: 1188407-46-6

Related OROGO articles

These editorial links discuss the product family, workflow or sourcing context. They are not lot specifications or evidence that every statement applies to this product.

OROGO article

Key Quality Attributes for Modified Nucleotides

Important quality attributes for modified nucleotide sourcing, including purity basis, water content, counterion, storage and enzyme compatibility.

OROGO article

RNA-Based Skincare Is Becoming a Materials Question

PDRN, siRNA, miRNA and tFNA are being discussed together in skincare, but they are different materials with different evidence and formulation questions.

OROGO article

INTerpath-001 Is Positive, but the Phase 3 Effect Size Is Still Missing

INTerpath-001 met RFS and DMFS endpoints, but Phase 3 effect sizes, subgroup results and mature overall survival data remain pending.

Request a quote Review request checklist

Technology platforms

Catalog-derived platform membership for navigating related chemistry and verifiable product sets.

Nucleoside & nucleotide chemistry

View platform scope

mRNA raw-material platform

View platform scope

General selection guidance for evaluating this product family. Confirm the exact product specification and workflow requirements separately.

Choosing modified nucleosides and nucleotides

Review form, hydration, workflow compatibility, analytical basis and storage before use.

Open technical guide